Form 4: Core Laboratories Director Katherine Murray Reports Stock Transactions

Director Katherine Murray reports acquisition and disposal of Core Laboratories Inc. stock and restricted shares on April 1, 2025.

Summary

• On April 1, 2025, Katherine Murray, a director of Core Laboratories Inc., reported transactions involving the company's stock.
• Murray acquired 8,069 restricted shares and disposed of 9,317 common stock shares.
• The restricted shares were acquired at a price of $0 and will vest on April 1, 2026.
• The vested restricted shares were disposed of at a price of $0.
• Following these transactions, Murray directly owns 8,069 derivative securities and 21,221 common stock shares.

Sentiment

Score: 5

Explanation: This is a neutral report of stock transactions by a company director, with no inherent positive or negative sentiment.

Future Outlook

The restricted shares will vest on April 1, 2026, subject to the terms of issuance.

Industry Context

This Form 4 filing is a routine disclosure required by the SEC for corporate insiders, providing transparency into their trading activities. It allows investors to monitor the actions of company directors and officers.

Stakeholder Impact

• The transactions may be of interest to shareholders as they provide insight into the actions of a company director.

Key Dates

Keywords

Core Laboratories Inc., Katherine Murray, stock transactions, restricted shares, Form 4, director, CLB